News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,488 Results
Type
Article (577)
Company Profile (3)
Press Release (3908)
Section
Business (1339)
Career Advice (17)
Deals (154)
Drug Delivery (2)
Drug Development (417)
Employer Resources (1)
FDA (69)
Job Trends (89)
News (1936)
Policy (93)
Tag
Academia (74)
Alliances (346)
Alzheimer's disease (3)
Approvals (66)
Bankruptcy (1)
Best Places to Work (64)
Breast cancer (9)
Cancer (16)
Cardiovascular disease (3)
Career advice (15)
Cell therapy (4)
Clinical research (288)
Collaboration (6)
COVID-19 (17)
CRISPR (1)
Cystic fibrosis (4)
Data (7)
Diagnostics (38)
Earnings (323)
Employer resources (1)
Events (611)
Executive appointments (3)
FDA (72)
Featured Employer (1)
Funding (6)
Gene editing (5)
Gene therapy (1)
GLP-1 (4)
Government (24)
Guidances (1)
Healthcare (94)
Infectious disease (18)
Inflammatory bowel disease (1)
Influenza (1)
Interviews (2)
IPO (64)
Job creations (21)
Job search strategy (15)
Layoffs (1)
Legal (15)
Lung cancer (2)
Manufacturing (6)
Medical device (88)
Medtech (88)
Mergers & acquisitions (98)
Metabolic disorders (1)
Neuroscience (3)
NextGen: Class of 2025 (50)
Non-profit (27)
Northern California (13)
Now hiring (1)
Obesity (1)
Opinion (1)
Pancreatic cancer (1)
Patents (1)
People (557)
Phase I (149)
Phase II (138)
Phase III (49)
Pipeline (2)
Postmarket research (4)
Preclinical (95)
Press Release (5)
Prostate cancer (2)
Rare diseases (4)
Real estate (53)
Recruiting (1)
Regulatory (63)
Reports (3)
Research institute (61)
Resumes & cover letters (3)
Southern California (6)
Startups (47)
United States (158)
Venture capitalists (1)
Date
Today (1)
Last 7 days (5)
Last 30 days (25)
Last 365 days (253)
2025 (33)
2024 (245)
2023 (293)
2022 (417)
2021 (417)
2020 (311)
2019 (293)
2018 (237)
2017 (234)
2016 (294)
2015 (312)
2014 (185)
2013 (126)
2012 (128)
2011 (209)
2010 (159)
Location
Africa (5)
Alabama (1)
Asia (442)
Australia (38)
California (24)
Canada (2)
China (2)
Colorado (2)
Connecticut (15)
Europe (349)
Florida (3)
Maryland (4)
Massachusetts (18)
Michigan (2)
Minnesota (8)
New Jersey (8)
New Mexico (2)
New York (12)
North Carolina (49)
Northern California (13)
Pennsylvania (6)
South America (8)
Southern California (6)
Texas (6)
Washington State (5)
4,488 Results for "chimera bioengineering".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Proteolysis Targeting Chimeras (PROTACs) In Cancer Therapy
October 10, 2024
·
3 min read
Genetown
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting
Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.
May 1, 2024
·
3 min read
Press Releases
Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
January 21, 2025
·
5 min read
Asian Fund for Cancer Research Announces Chimera Bioengineering as the 2021 BRACE Award Venture Competition Winner
Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Research’s (AFCR) 2021 BRACE Award Venture Competition —a first-of-its-kind program for early stage oncology technology companies focused on Asian-prevalent cancers.
April 28, 2022
·
4 min read
Pharm Country
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
Cell BioEngines, Inc. announced that Dr. Ajay Vishwakarma, Founder and CEO of Cell BioEngines, will be presenting at the BIO CEO & Investor Conference at 2:00 p.m. EST on Monday, February 26, 2024.
February 8, 2024
·
2 min read
BioCapital
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants.
April 2, 2024
·
2 min read
Business
Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
Chimera Bioengineering a biotherapeutics company building next-generation CAR-T therapeutics focused primarily on solid tumors, announced the appointment of Vlad Hogenhuis, M.D., as Chief Executive Officer.
April 28, 2022
·
5 min read
Pharm Country
Cell BioEngines Enters Agreement with Miltenyi Bioindustry to Manufacture Hematopoietic Cell Therapy Clinical Program
Cell BioEngines, Inc. announced an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation product for clinical use in hematology-oncology.
December 29, 2023
·
3 min read
Pharm Country
SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to BeCell BioEngines, Inc moves to Manhattan, New York, to leverage the city’s focus and strategic investment in biotech
Cell BioEngines, Inc., founded by visionary Dr. Ajay Vishwakarma aiming to turn cancer into a curable disease announced that the SOSV-backed company will establish its executive headquarters in NYC, a hub for the fast-growing life-science ecosystem across New York state.
January 13, 2024
·
2 min read
Business
BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs
BioLoomics, a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells, announced that Kurt Gish, Ph.D., has joined as the Chief Scientific Officer.
June 13, 2024
·
2 min read
1 of 449
Next
